Major Depression: Clinical Trials

2 trials for Major Depression, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Terminated 2
Phase 21Terminated 1

Follow Major Depression: new trials by email Literature Review of Major Depression trials Research Report on Major Depression

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Omega 3 FA Supplements as Augmentation in the Treatment of Depression
Desvenlafaxine, Omega 3 Fatty acids, Placebo (for Omega 3 fatty acid supplement) - Major Depression, Cancer
Phase 2 / Phase 3TerminatedUConn Health62013-02-012017-12-27
Efficacy and Safety of Homeopathy for Moderate Depression (Acute Phase)
homeopathic q-potencies, Placebo, homeopathic case history taking type I - Major Depression
Phase 3TerminatedCharite University, Berlin, Germany442010-08-012012-07-10

Narrower conditions

Depression (2)  ·  Depressive Disorder, Major (2)  ·  Cardiovascular Diseases (1)  ·  Diabetes Mellitus (1)  ·  Hypertension (1)  ·  Neoplasms (1)

Broader conditions

Behavior (2)  ·  Behavioral Symptoms (2)  ·  Depressive Disorder (2)  ·  Mental Disorders (2)  ·  Mood Disorders (2)  ·  Endocrine System Diseases (1)  ·  Glucose Metabolism Disorders (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Vascular Diseases (1)

Interventions

Desvenlafaxine Succinate (1)  ·  Fatty Acids, Omega-3 (1)

Sponsors

Charite University, Berlin, Germany (1)  ·  UConn Health (1)

Countries

Germany (1)  ·  United States (1)

Top investigators

Claudia M. Witt, MD (1)  ·  Jayesh Kamath, MD PhD (1)

Results publications

PMID 24086352

NIH funding

2009 (1)